糖化アルブミン測定法市場：製品、用途、エンドユーザー別-2024-2030年の世界予測

糖化アルブミン測定法市場規模は2023年に2億1,729万米ドルと推定され、2024年には2億3,269万米ドルに達すると予測され、CAGR 7.51%で2030年には3億6,092万米ドルに達する見込みです。

糖化アルブミン測定法の世界市場

糖化アルブミンは、糖尿病の評価とモニタリングに使用されるバイオマーカーで、糖化ヘモグロビン（HbA1c）などの他のバイオマーカーと比較して、血糖値の短期的な変化を反映します。糖尿病の有病率が上昇し、血糖値のモニタリングとコントロールに対する一般市民の意識が高まっていることから、正確で信頼性の高い検査法の必要性が高まっています。しかし、各国の償還政策や規制の枠組みが、糖化アルブミン測定法の普及を妨げている可能性があります。とはいえ、新興国におけるヘルスケアインフラの拡大により、糖化アルブミン測定法のような高度な診断ツールへのアクセスが向上し、グルコース調節のための新規バイオマーカーの研究により、糖化アルブミン測定法市場の新たな成長の道が開けると期待されています。

地域別の洞察

南北アメリカは、糖尿病の有病率が高いため、糖化アルブミン測定法に対するニーズが高く、糖化アルブミン測定法市場において重要な地位を占めています。また、糖化アルブミン測定法のような革新的な診断ツールの導入をサポートする先進的なヘルスケアシステムを有しています。欧州における高齢化の進展は、糖化アルブミン測定法のような先進的診断薬に対する需要の増加に大きく寄与しています。EU諸国は糖尿病などの疾患の早期発見を優先する包括的なヘルスケアシステムを有しており、同地域における糖化アルブミン測定法の需要を高めています。中東・アフリカ地域では、人口動態の変化や都市化により、糖尿病を含む生活習慣病が着実に増加しています。同地域では、法的機関による様々なプログラム、イニシアチブ、投資が革新的な診断技術の採用を促進しています。糖尿病有病率の増加、研究開発活動の活発化、糖化アルブミン検出のための新規技術開発における著しい進歩により、アジア太平洋地域の糖化アルブミン測定法市場は急速に拡大しています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは糖化アルブミン測定法市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、糖化アルブミン測定法市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-糖化アルブミン測定法市場の市場規模および予測は？

2-糖化アルブミン測定法市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-糖化アルブミン測定法市場における技術動向と規制の枠組みは？

4-糖化アルブミン測定法市場における主要ベンダーの市場シェアは？

5-糖化アルブミン測定法市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で糖尿病の有病率が上昇
    • 予防ヘルスケア対策への注目の高まり
    • 医療専門家にとって有利な償還ポリシー
  • 抑制要因
    • 糖化アルブミン検査に関する認識の欠如と検査に関連する高額な費用
  • 機会
    • 技術の進歩により、精度と感度が向上し、アッセイ方法が改善されました
    • 糖尿病の早期スクリーニングプログラムなどの政府の取り組み
  • 課題
    • 異なる研究室間で標準化されたプロトコルが利用できないと、結果に不一致が生じる
• 市場セグメンテーション分析
  • 製品：病気のメカニズムを理解するために動物の糖化アルブミン測定法の使用を増やす
  • アプリケーション：健康上の合併症を防ぐため、1型糖尿病の検出に糖化アルブミン測定法を大幅に採用
  • エンドユーザー：診断検査機関での糖化アルブミン測定法の使用率が高い
• 市場動向分析
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み

第6章 糖化アルブミン測定法市場：製品別

• 動物糖化アルブミン測定法
• 人間の糖化アルブミン測定法

第7章 糖化アルブミン測定法市場：用途別

• 前糖尿病
• 1型糖尿病
• 2型糖尿病

第8章 糖化アルブミン測定法市場：エンドユーザー別

• 糖尿病ケアセンター
• 診断研究所
• 病院とクリニック

第9章 南北アメリカの糖化アルブミン測定法市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の糖化アルブミン測定法市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの糖化アルブミン測定法市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ主要企業別の分析
  • 合併・買収

第13章 競争力のあるポートフォリオ

• 主要な企業プロファイル
  • Abcam PLC
  • Abnova Corporation
  • Asahi Kasei Corporation
  • Beijing Strong Biotechnologies Inc.
  • Cardinal Health Inc.
  • Crystal Chem Inc.
  • Diazyme Laboratories Inc.
  • DxGen Corp.
  • EKF Diagnostics Holdings PLC
  • Epinex Diagnostics Inc.
  • Ethos Biosciences, Inc.
  • FroggaBio Inc.
  • Hymes Biotech
  • Laboratory Corporation of America Holdings
  • LifeSpan BioSciences, Inc.
  • Weldon Biotech Inc.
• 主要な製品ポートフォリオ

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. GLYCATED ALBUMIN ASSAY MARKET RESEARCH PROCESS
• FIGURE 2. GLYCATED ALBUMIN ASSAY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLYCATED ALBUMIN ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLYCATED ALBUMIN ASSAY MARKET DYNAMICS
• FIGURE 7. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 12. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. GLYCATED ALBUMIN ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
• FIGURE 22. GLYCATED ALBUMIN ASSAY MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

• TABLE 1. GLYCATED ALBUMIN ASSAY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLYCATED ALBUMIN ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 6. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY ANIMAL GLYCATED ALBUMIN ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY HUMAN GLYCATED ALBUMIN ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 9. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PREDIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 13. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY DIABETIC CARE CENTRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLYCATED ALBUMIN ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. CANADA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. CANADA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. CANADA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. CHINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. CHINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. CHINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. INDIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. INDIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. INDIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. ITALY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. ITALY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ITALY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. POLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. POLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. POLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. QATAR GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. QATAR GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. QATAR GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. GLYCATED ALBUMIN ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
• TABLE 144. GLYCATED ALBUMIN ASSAY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 145. GLYCATED ALBUMIN ASSAY MARKET LICENSE & PRICING

[191 Pages Report] The Glycated Albumin Assay Market size was estimated at USD 217.29 million in 2023 and expected to reach USD 232.69 million in 2024, at a CAGR 7.51% to reach USD 360.92 million by 2030.

Global Glycated Albumin Assay Market

Glycated albumin is a biomarker used for assessing and monitoring diabetes mellitus, reflecting shorter-term changes in blood glucose levels compared to other biomarkers such as glycated hemoglobin (HbA1c). The rising prevalence of diabetes and increasing public awareness about monitoring and controlling blood glucose raises need for accurate and reliable testing methods. However, reimbursement policies and regulatory frameworks in various countries may hinder the widespread use of glycated albumin assays. Nevertheless, expanding healthcare infrastructure in emerging economies provides greater access to advanced diagnostics tools such as glycated albumin assays, and research into novel biomarkers for glucose regulation is expected to create new avenues for growth within the glycated albumin assay market.

Regional Insights

The Americas has a significant landscape in the glycated albumin assay market owing to a substantial need for glycated albumin assay due to the high prevalence of diabetes in these countries. Additionally, countries have advanced healthcare systems that can support the adoption of innovative diagnostic tools such as glycated albumin assays. The growing aging population in Europe contributes significantly to the increasing demand for advanced diagnostics such as glycated albumin assays. EU countries have comprehensive healthcare systems that prioritize early detection of diseases such as diabetes, increasing the glycated albumin assay demand in the region. In the Middle East and Africa region, there has been a steady rise in lifestyle-related diseases, including diabetes, due to changing demographics and urbanization. Various programs, initiatives, and investments by legal authorities promoted the adoption of innovative diagnostic techniques in the region. The Asia Pacific market for glycated albumin assay is expanding rapidly due to the growing prevalence of diabetes, increasing research and development activities, and significant advancements in developing novel techniques for glycated albumin detection.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Glycated Albumin Assay Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Glycated Albumin Assay Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Glycated Albumin Assay Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Asahi Kasei Corporation, Beijing Strong Biotechnologies Inc., Cardinal Health Inc., Crystal Chem Inc., Diazyme Laboratories Inc., DxGen Corp., EKF Diagnostics Holdings PLC, Epinex Diagnostics Inc., Ethos Biosciences, Inc., FroggaBio Inc., Hymes Biotech, Laboratory Corporation of America Holdings, LifeSpan BioSciences, Inc., and Weldon Biotech Inc..

Market Segmentation & Coverage

This research report categorizes the Glycated Albumin Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Animal Glycated Albumin Assay
  • Human Glycated Albumin Assay
• Application
  • Prediabetes
  • Type 1 Diabetes
  • Type 2 Diabetes
• End User
  • Diabetic Care Centres
  • Diagnostic Laboratories
  • Hospitals & Clinics
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Glycated Albumin Assay Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Glycated Albumin Assay Market?

3. What are the technology trends and regulatory frameworks in the Glycated Albumin Assay Market?

4. What is the market share of the leading vendors in the Glycated Albumin Assay Market?

5. Which modes and strategic moves are suitable for entering the Glycated Albumin Assay Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Glycated Albumin Assay Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of diabetes worldwide
    • 5.1.1.2. Increased focus on preventive healthcare measures
    • 5.1.1.3. Favorable reimbursement policies for medical professionals
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of awareness about glycated albumin testing and high cost associated with assays
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in technology for improved assay methodologies with enhanced accuracy and sensitivity
    • 5.1.3.2. Government initiatives such as early screening programs for diabetes
  • 5.1.4. Challenges
    • 5.1.4.1. Unavailability of standardized protocols across different laboratories leads to inconsistencies in results
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing use of animal glycated albumin assay to understand disease mechanisms
  • 5.2.2. Application: Significant adoption of glycated albumin assay for detection of type 1 diabetes owing to prevent health complications
  • 5.2.3. End User: High usage of glycated albumin assay in diagnostic laboratories
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Glycated Albumin Assay Market, by Product

• 6.1. Introduction
• 6.2. Animal Glycated Albumin Assay
• 6.3. Human Glycated Albumin Assay

7. Glycated Albumin Assay Market, by Application

• 7.1. Introduction
• 7.2. Prediabetes
• 7.3. Type 1 Diabetes
• 7.4. Type 2 Diabetes

8. Glycated Albumin Assay Market, by End User

• 8.1. Introduction
• 8.2. Diabetic Care Centres
• 8.3. Diagnostic Laboratories
• 8.4. Hospitals & Clinics

9. Americas Glycated Albumin Assay Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Glycated Albumin Assay Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Glycated Albumin Assay Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player
  • 12.3.1. Merger & Acquisition
    • 12.3.1.1. Sartorius Agrees to Acquire Albumedix

13. Competitive Portfolio

• 13.1. Key Company Profiles
  • 13.1.1. Abcam PLC
  • 13.1.2. Abnova Corporation
  • 13.1.3. Asahi Kasei Corporation
  • 13.1.4. Beijing Strong Biotechnologies Inc.
  • 13.1.5. Cardinal Health Inc.
  • 13.1.6. Crystal Chem Inc.
  • 13.1.7. Diazyme Laboratories Inc.
  • 13.1.8. DxGen Corp.
  • 13.1.9. EKF Diagnostics Holdings PLC
  • 13.1.10. Epinex Diagnostics Inc.
  • 13.1.11. Ethos Biosciences, Inc.
  • 13.1.12. FroggaBio Inc.
  • 13.1.13. Hymes Biotech
  • 13.1.14. Laboratory Corporation of America Holdings
  • 13.1.15. LifeSpan BioSciences, Inc.
  • 13.1.16. Weldon Biotech Inc.
• 13.2. Key Product Portfolio

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing